Inventor · disambiguated record
Richard Thomas Beresis
Also filed as: BERESIS RICHARD · BERESIS RICHARD T · BERESIS RICHARD THOMAS
38 granted patents·19 pending applications·657 citations·filing 2000–2024
98Inventor score
Files withSAGE THERAPEUTICS INC23MERCK SHARP & DOHME9UNIV CALIFORNIA5COLLETTI STEVEN L3DYNAVAX TECH CORP3
Top patents by PatentIndex Score
57 records- 0198US11241446B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2019·Granted Feb 8, 2022·12 cites·15 claims
- 0298US9512165B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2014·Granted Dec 6, 2016·71 cites·2 claims
- 0397US10822370B219-nor neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Nov 3, 2020·13 cites·24 claims
- 0497US10774108B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2015·Granted Sep 15, 2020·12 cites·18 claims
- 0597US10342810B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Jul 9, 2019·17 cites·16 claims
- 0697US10172871B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2016·Granted Jan 8, 2019·20 cites·12 claims
- 0797US9725481B219-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2014·Granted Aug 8, 2017·46 cites·26 claims
- 0897US9365611B219-NOR neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2014·Granted Jun 14, 2016·49 cites·25 claims
- 0996US11945836B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2022·Granted Apr 2, 2024·3 cites·20 claims
- 1096US11344563B219-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2019·Granted May 31, 2022·8 cites·20 claims
- 1196US6498165B1Src kinase inhibitor compoundsMERCK & CO INC·Filed 2000·Granted Dec 24, 2002·238 cites·39 claims
- 1294US9663522B23-aminocycloalkyl compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2013·Granted May 30, 2017·15 cites·22 claims
- 1393US10391106B219-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2017·Granted Aug 27, 2019·10 cites·3 claims
- 1493US10023606B219-nor neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2016·Granted Jul 17, 2018·11 cites·28 claims
- 1592US11261211B219-NOR neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2019·Granted Mar 1, 2022·8 cites·24 claims
- 1691US10377790B219-nor neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2016·Granted Aug 13, 2019·8 cites·28 claims
- 1791US9603838B2RORgammaT inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Mar 28, 2017·16 cites·20 claims
- 1890US11827641B2Toll-like receptor antagonist compounds and methods of useDYNAVAX TECH CORP·Filed 2022·Granted Nov 28, 2023·1 cites·25 claims
- 1990US9556168B2N-alkylated indole and indazole compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2013·Granted Jan 31, 2017·16 cites·23 claims
- 2090US2025319106A119-nor c3, 3-disubstituted c21-n-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2189US9487490B23-cyclohexenyl and cyclohexyl substituted indole and indazole compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2013·Granted Nov 8, 2016·15 cites·24 claims
- 2289US9095583B2RORgammaT inhibitorsKARSTENS WILLEM FREDERIK JOHAN·Filed 2012·Granted Aug 4, 2015·25 cites·19 claims
- 2386US11370794B2Toll-like receptor antagonist compounds and methods of useDYNAVAX TECH CORP·Filed 2017·Granted Jun 28, 2022·3 cites·28 claims
- 2486US9745265B24-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2013·Granted Aug 29, 2017·9 cites·29 claims
- 2583US9884043B2RORgammaT inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Feb 6, 2018·4 cites·19 claims
- 2683US2024076310A1Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2782US12201640B219-nor C3,3-disubstituted C21-n-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Jan 21, 2025·0 cites·21 claims
- 2882US8933113B2Mineralocorticoid receptor antagonistsCRESPO ALEJANDRO·Filed 2012·Granted Jan 13, 2015·11 cites·17 claims
- 2981US2025042934A1Compositions and methods for treating cns disordersSAGE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3079US12378255B2Toll-like receptor antagonist compounds and methods of useDYNAVAX TECH CORP·Filed 2023·Granted Aug 5, 2025·0 cites·17 claims
- 3178US10196354B24-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2017·Granted Feb 5, 2019·2 cites·29 claims
- 3273US7196095B2(Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compoundsMERCK & CO INC·Filed 2002·Granted Mar 27, 2007·8 cites·25 claims
- 3372US2021061849A1Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3472US2021061850A1Neuroactive steriods, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3571US7411073B2Selective non-steroidal glucocorticoid receptor modulatorsMERCK & CO INC·Filed 2004·Granted Aug 12, 2008·5 cites·11 claims
- 3669US11912737B219-nor neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Feb 27, 2024·0 cites·33 claims
- 3768US2020165291A1Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3867US2016068563A119-nor neuroactive steroids and methods of use thereofHARRISON BOYD L·Filed 2014·Application pending·0 cites
- 3967US2021017218A1Compositions and methods for treating cns disordersSAGE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4062US10870635B2Compounds and their use as BACE1 inhibitorsALLGENESIS BIOTHERAPEUTICS INC·Filed 2016·Granted Dec 22, 2020·1 cites·12 claims
- 4159US2025145598A1Acid ceramidase inhibitors and uses thereofUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 4258US2024051965A1Oxygen-containing heterocyclic compound and use thereofICAHN SCHOOL MED MOUNT SINAI·Filed 2023·Application pending·0 cites
- 4354US2018179247A1Neuroactive steroids, compositions, and uses thereofBOTELLA GABRIEL MARTINEZ·Filed 2015·Application pending·0 cites
- 4453US11643388B2Inhibitors of alpha 2 beta 1 integrin and methods of use thereofUNIV CALIFORNIA·Filed 2021·Granted May 9, 2023·0 cites·20 claims
- 4553US9403807B2Mineralocorticoid receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Aug 2, 2016·0 cites·5 claims
- 4652US11530180B2Alpha-5 beta-1 inhibitorsUNIV CALIFORNIA·Filed 2020·Granted Dec 20, 2022·0 cites·21 claims
- 4752US2025179084A1OXADIAZOLYL DIHYDROPYRANO[2,3-b]PYRIDINE INHIBITORS OF HIPK2 FOR TREATING KIDNEY FIBROSISICAHN SCHOOL MED MOUNT SINAI·Filed 2022·Application pending·0 cites
- 4848US2010204278A1Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of TreatmentBERESIS RICHARD T·Filed 2007·Application pending·0 cites
- 4947US7662846B2Selective spirocyclic glucocorticoid receptor modulatorsMERCK SHARP & DOHME·Filed 2004·Granted Feb 16, 2010·0 cites·5 claims
- 5045US2009170891A1Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of TreatmentCOLLETTI STEVEN L·Filed 2007·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →